Real-world treatment patterns and outcomes in ER+/PR+/HER2+metastatic breast cancer (MBC) patients: A National Cancer Database analysis.

被引：2
|
作者：
Statler, Abby
Nahleh, Zeina A.
Hobbs, Brian
Wei, Wei
Gupta, Annie
Blake, Cassann N.
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin Florida, El Paso, TX USA
[3] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA
[4] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Cleveland Clin Florida, Weston, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1033
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment patterns and their impact on the outcome of patients with HR+/HER2+metastatic breast cancer in a large real-world cohort.
    Carausu, Marcela
    Carton, Matthieu
    Dieras, Veronique C.
    Petit, Thierry
    Lahaye, Severine Guiu
    Veyret, Corinne
    Goncalves, Anthony
    Augereau, Paule
    Ferrero, Jean-Marc
    Levy, Christelle
    Ung, Mony
    Desmoulins, Isabelle
    Debled, Marc
    Bachelot, Thomas
    Eymard, Jean-Christophe
    Pistilli, Barbara
    Frenel, Jean-Sebastien
    Chevrot, Michael
    Mailliez, Audrey
    Cabel, Luc
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR +, HER2-metastatic breast cancer patients in Japan
    Nozawa, K.
    Terada, M.
    Onishi, M.
    Ozaki, Y.
    Takano, T.
    Fakhouri, W.
    Novick, D.
    Haro, J. M.
    Faris, L. H.
    Kawaguchi, T.
    Tanizawa, Y.
    Tsurutani, Junji
    BREAST CANCER, 2023, 30 (04) : 657 - 665
  • [23] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR + , HER2- metastatic breast cancer patients in Japan
    K. Nozawa
    M. Terada
    M. Onishi
    Y. Ozaki
    T. Takano
    W. Fakhouri
    D. Novick
    J. M. Haro
    L. H. Faris
    T. Kawaguchi
    Y. Tanizawa
    Junji Tsurutani
    Breast Cancer, 2023, 30 : 657 - 665
  • [24] Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+metastatic breast cancer: an analysis of the SONABRE registry
    Geurts, Sandra M. E.
    Ibragimova, Khava I. E.
    Ding, Nan
    Meegdes, Marissa
    Erdkamp, Frans
    Heijns, Joan B.
    Tol, Jolien
    Vriens, Birgit E. P. J.
    Dercksen, Marcus W.
    Aaldering, Kirsten N. A.
    Pepels, Manon J. A. E.
    van de Winkel, Linda
    Peters, Natascha A. J. B.
    van de Wouw, Agnes J.
    Maaskant, Sabrina A. J. G.
    Teeuwen-Dedroog, Nathalie J. A.
    van Nijnatten, Thiemo J. A.
    de Boer, Maaike
    Tjan-Heijnen, Vivianne C. G.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (02) : 287 - 302
  • [25] Treatment (tx) patterns and clinical outcomes for patients (pts) with de novo versus recurrent HER2+metastatic breast cancer (MBC)
    Brufsky, Adam
    Yardley, Denise Aysel
    Kaufman, Peter Andrew
    Yood, Marianne Ulcickas
    Rugo, Hope S.
    Mayer, Musa
    Quah, Cheng Seok
    Yoo, Bongin
    Tripathy, Debu
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] Treatment goals and quality of life (QOL) in a survey of patients with ER+/HER2-metastatic breast cancer (mBC)
    Sammons, Sarah L.
    Meisel, Jane
    Shanahan, Kelly
    Pluard, Timothy
    Kozlowski, Monica
    Carroll, Dominic
    Attias, Elizabeth
    CANCER RESEARCH, 2023, 83 (05)
  • [27] The role of adjuvant endocrine treatment in ER+, PR−, HER2− early breast cancer: a retrospective study of real-world data
    Miaochun Zhong
    Xiaoqiu Ren
    Wenjie Xia
    Yangyang Qian
    Kewang Sun
    Jun Wu
    Scientific Reports, 14 (1)
  • [28] Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2-metastatic breast cancer
    Cuyun Carter, Gebra
    Sheffield, Kristin M.
    Gossai, Anala
    Huang, Yu-Jing
    Zhu, Yajun Emily
    Bowman, Lee
    Nash Smyth, Emily
    Mathur, Raina
    Cohen, Aaron B.
    Rasmussen, Erik
    Balakrishna, Shreya
    Morato Guimaraes, Claudia
    Rybowski, Sarah
    Seidman, Andrew D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (07) : 1179 - 1187
  • [29] Treatment Patterns and Associated Outcomes Among Patients with HER2+Metastatic Breast Cancer in the United States
    Lam, Clara
    Della Varghese
    Nordstrom, Beth L.
    Murphy, Brian
    Collins, Jenna
    Mehta, Sandhya
    CANCER RESEARCH, 2023, 83 (05)
  • [30] Real-world clinical outcomes and treatment patterns among metastatic breast cancer (MBC) patients with germline BRCA mutation (gBRCAmut).
    Quek, Ruben
    Mardekian, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345